preeclampsia - Nursing Case Study

Pathophysiology

• Primary mechanism: Abnormal placentation leads to impaired trophoblastic invasion of the spiral arteries, resulting in inadequate remodeling and high-resistance uteroplacental circulation, which induces placental ischemia and oxidative stress.

• Secondary mechanism: The ischemic placenta releases anti-angiogenic factors like sFlt-1 and endoglin into the maternal circulation, disrupting endothelial function and causing systemic vasoconstriction and hypertension.

• Key complication: Endothelial dysfunction leads to widespread systemic manifestations including proteinuria, edema, organ dysfunction (e.g., renal, hepatic, cerebral), and increased risk of severe complications such as eclampsia and HELLP syndrome.

Patient Profile

Demographics:

32-year-old female, office manager

History:

• Key past medical history: Chronic hypertension, Type 2 diabetes, previous preeclampsia in first pregnancy

• Current medications: Labetalol, Metformin, Prenatal vitamins

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and visual disturbances

• Key symptoms: Sudden weight gain, upper abdominal pain, edema in hands and face, nausea

• Vital signs: Blood pressure 190/120 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the healthcare team conducts an initial assessment, they note significant findings that heighten concern regarding the patient's condition. Physical examination reveals pronounced pitting edema in the lower extremities and facial edema. Neurological assessment shows brisk deep tendon reflexes and clonus, suggesting increased neuromuscular excitability and potential cerebral involvement. The patient reports persistent visual disturbances, including seeing spots and blurring, raising concerns about severe preeclampsia with possible progression to eclampsia.

Laboratory results return showing proteinuria with a 24-hour urine protein collection of 3.8 grams, confirming significant renal involvement. Liver function tests reveal elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, indicating hepatic strain, while complete blood count shows thrombocytopenia with a platelet count of 90,000/mm³, increasing the suspicion of HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelet count). Serum creatinine is elevated at 1.8 mg/dL, reflecting impaired renal function.

In response to these findings, the clinical team escalates care. They initiate intravenous magnesium sulfate for seizure prophylaxis, given the neurological symptoms and high risk of eclampsia. Antihypertensive therapy is adjusted with the addition of hydralazine for more effective blood pressure control. The obstetrics team prepares for possible urgent delivery, as maternal stabilization takes precedence, and fetal monitoring is intensified to assess for signs of fetal distress. The critical challenge now lies in balancing maternal and fetal risks, necessitating advanced clinical judgment to determine the timing and mode of delivery that optimizes outcomes for both mother and child.

Section 2

As the healthcare team continues to monitor the patient closely, a sudden change in her status prompts immediate concern. The patient begins to experience severe epigastric pain, a significant red flag indicating possible hepatic involvement and further complication of the ongoing HELLP syndrome. Her blood pressure remains dangerously elevated at 180/115 mmHg despite the adjusted antihypertensive regimen, underscoring the difficulty in achieving adequate blood pressure control and the potential for rapid deterioration.

New laboratory results reveal a further decline in platelet count to 75,000/mm³, coupled with increasing liver enzymes, with AST skyrocketing to 450 U/L and ALT to 500 U/L, confirming worsening hepatic dysfunction. Concurrently, the patient develops oliguria, with urine output dropping to less than 20 mL/hour, highlighting a critical decline in renal function. These findings necessitate a reevaluation of the current treatment plan and prompt discussions among the multidisciplinary team regarding the urgent need for delivery to prevent further maternal and fetal compromise.

The fetal monitoring reports intermittent late decelerations, indicating possible fetal distress, which compounds the urgency of the situation. The obstetric team, in consultation with maternal-fetal medicine specialists, decides that expedited delivery is paramount. Given the patient's unstable condition and risk of hemorrhage due to thrombocytopenia, a cesarean delivery is planned under careful anesthetic management to minimize maternal risk. The team prepares for potential neonatal resuscitation, as the combination of maternal instability and fetal distress presents a high-risk scenario necessitating advanced neonatal care post-delivery. This critical juncture in the patient's journey demands precise coordination and expert clinical judgment to navigate the complexities of severe preeclampsia and HELLP syndrome effectively.

Section 3

As the team prepares for the cesarean delivery, a sudden change in the patient's neurological status raises immediate alarm. The patient begins to exhibit confusion and disorientation, coupled with a noticeable decrease in responsiveness. She struggles to follow simple commands, and her speech becomes slurred, indicating potential cerebral involvement, likely secondary to severe hypertension and the underlying HELLP syndrome. A quick assessment reveals a brisk patellar reflex and clonus, suggesting heightened neurological irritability. These findings heighten the concern for an imminent eclamptic seizure, further complicating the clinical scenario.

In response to the evolving situation, the healthcare team administers a bolus of magnesium sulfate intravenously, aiming to stabilize the patient's neurological status and prevent convulsive activity. Continuous monitoring of the patient's reflexes, respiratory rate, and oxygen saturation is initiated to ensure safety and efficacy of the treatment. Despite these measures, the patient's blood pressure remains critically high, fluctuating between 185/120 mmHg and 190/125 mmHg, indicating refractory hypertension. This necessitates the addition of intravenous labetalol to the antihypertensive regimen, with a plan to titrate the dosage based on frequent blood pressure assessments.

Amidst these developments, fetal monitoring reveals persistent late decelerations with a decreased variability, amplifying concerns for fetal hypoxia. The obstetric and anesthesia teams coordinate rapidly, prioritizing maternal stabilization while preparing the surgical suite for an urgent cesarean delivery. As the situation intensifies, the neonatology team is placed on high alert, ready to manage potential complications in the newborn, including respiratory distress and metabolic imbalances. This critical escalation underscores the necessity for seamless multidisciplinary collaboration, as the team navigates through the intricacies of severe preeclampsia compounded by neurological and fetal complications.

Section 4

As the healthcare team works diligently to stabilize the patient, new diagnostic results arrive, revealing significant insights into the patient's deteriorating condition. A recent CT scan of the brain indicates the presence of cerebral edema, consistent with posterior reversible encephalopathy syndrome (PRES), a known complication of severe preeclampsia. This finding aligns with the patient's neurological symptoms and reinforces the need for aggressive management of her hypertension and cerebral protection. Laboratory results further complicate the picture, showing a marked increase in liver enzymes—AST and ALT levels are now three times the upper limit of normal—and a platelet count that has dropped to 65,000/mm^3, confirming the progression of HELLP syndrome.

In light of these findings, the team intensifies their efforts to mitigate cerebral involvement and organ dysfunction. The magnesium sulfate infusion is carefully monitored and adjusted to maintain therapeutic levels, while the labetalol dosage is increased incrementally to achieve better blood pressure control. The patient's urine output is closely tracked via a Foley catheter to assess renal perfusion and prevent acute kidney injury. Fetal heart rate monitoring continues to show late decelerations, prompting the obstetric team to expedite preparations for the cesarean delivery, balancing the urgency of maternal stabilization against fetal distress.

Despite these interventions, a new complication emerges: the patient begins to exhibit signs of pulmonary edema, likely secondary to fluid overload from aggressive intravenous therapy and compromised cardiac function. Auscultation of the lungs reveals bilateral crackles, and the patient's oxygen saturation drops to 88% on room air, necessitating supplemental oxygen via a non-rebreather mask. This development necessitates a reevaluation of fluid management strategies, with the introduction of diuretics to alleviate the pulmonary congestion. The team remains vigilant, aware that each intervention carries potential risks and benefits, requiring constant reassessment and adaptation in this complex clinical scenario.

Section 5

As the healthcare team continues to manage the evolving clinical picture, a change in the patient's status becomes evident. Despite aggressive blood pressure control and the introduction of diuretics to address the pulmonary edema, the patient's respiratory status further deteriorates. Her respiratory rate increases to 30 breaths per minute, and her oxygen saturation remains low at 86% despite supplemental oxygen. The patient's work of breathing is visibly increased, with the use of accessory muscles and nasal flaring. This prompts the team to perform an arterial blood gas (ABG) analysis, which reveals a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicating acute respiratory acidosis and hypoxemia.

In response to these findings, the team initiates non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce the work of breathing. The decision is made to withhold further fluid administration, and the diuretic therapy is adjusted to optimize fluid balance and prevent further overload. Meanwhile, the obstetric team is on standby, prepared to proceed with the cesarean delivery as soon as the patient's respiratory status stabilizes. Close collaboration between the intensive care and obstetric teams is critical to provide the best possible outcomes for both the mother and the fetus.

The situation remains precarious, as the patient's multi-organ involvement requires careful coordination of treatment strategies. The medical team is acutely aware of the delicate balance between maintaining maternal stability and addressing fetal distress. Continuous monitoring and frequent reassessment are essential, as the patient's condition can change rapidly. The focus is now on stabilizing her respiratory status while preparing for potential escalation in care, including the possibility of mechanical ventilation should her condition not improve with current interventions.